HIV Research

Gender Based Risks for HIV among Drug Users Jeffrey Laurence, M.D. November was a stellar month for the publication of research linked to amfAR funded fellows. And it was a very international representation. Three of these young researchers, all Mathilde

amfAR Fellow explores the signals required for activating latently infected T cells and the virus within them.

More than 50 leading public and private sector HIV researchers, AIDS treatment advocates, and U.S. government officials convene to discuss HIV cure-related research.?

A New Type of Vaginal Microbicide by Jeffrey Laurence, M.D. October 2011?A vaginal microbicide?a substance that, when inserted into the vagina, can prevent HIV infection?would be a huge achievement in HIV prevention. As Dr. Navid Madani, an amfAR Mathilde

An Animal Model for a Functional Cure for AIDS Jeffrey Laurence, M.D. September 2011 A very small proportion of HIV infected people experience long term control of viral growth and disease progression in the absence of any antiretroviral therapy. And